Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

Boyd Yount, Kristopher M. Curtis, Elizabeth A. Fritz, Lisa E. Hensley, Peter B. Jahrling, Erik Prentice, Mark R. Denison, Thomas Geisbert, Ralph S. Baric

Research output: Contribution to journalArticle

210 Citations (Scopus)

Abstract

A previously undescribed coronavirus (CoV) is the etiologic agent responsible for severe acute respiratory syndrome (SARS). Using a panel of contiguous cDNAs that span the entire genome, we have assembled a full-length cDNA of the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV) that contained the expected marker mutations inserted into the component clones. Recombinant viruses replicated as efficiently as WT virus and both were inhibited by treatment with the cysteine proteinase inhibitor (2S,3S)-transepoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester. In addition, subgenomic transcripts were initiated from the consensus sequence ACGAAC in both the WT and infectious clone SARS-CoV. Availability of a SARS-CoV full-length cDNA provides a template for manipulation of the viral genome, allowing for the rapid and rational development and testing of candidate vaccines and therapeutics against this important human pathogen.

Original languageEnglish (US)
Pages (from-to)12995-13000
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume100
Issue number22
DOIs
StatePublished - Oct 28 2003
Externally publishedYes

Fingerprint

Reverse Genetics
Severe Acute Respiratory Syndrome
Coronavirus
Complementary DNA
Clone Cells
SARS Virus
Viruses
Cysteine Proteinase Inhibitors
Viral Genome
Consensus Sequence
Esters
Vaccines
Genome
Mutation

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. / Yount, Boyd; Curtis, Kristopher M.; Fritz, Elizabeth A.; Hensley, Lisa E.; Jahrling, Peter B.; Prentice, Erik; Denison, Mark R.; Geisbert, Thomas; Baric, Ralph S.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, No. 22, 28.10.2003, p. 12995-13000.

Research output: Contribution to journalArticle

Yount, Boyd ; Curtis, Kristopher M. ; Fritz, Elizabeth A. ; Hensley, Lisa E. ; Jahrling, Peter B. ; Prentice, Erik ; Denison, Mark R. ; Geisbert, Thomas ; Baric, Ralph S. / Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus. In: Proceedings of the National Academy of Sciences of the United States of America. 2003 ; Vol. 100, No. 22. pp. 12995-13000.
@article{4541dab54524477ea0f33c39caa6d6fe,
title = "Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus",
abstract = "A previously undescribed coronavirus (CoV) is the etiologic agent responsible for severe acute respiratory syndrome (SARS). Using a panel of contiguous cDNAs that span the entire genome, we have assembled a full-length cDNA of the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV) that contained the expected marker mutations inserted into the component clones. Recombinant viruses replicated as efficiently as WT virus and both were inhibited by treatment with the cysteine proteinase inhibitor (2S,3S)-transepoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester. In addition, subgenomic transcripts were initiated from the consensus sequence ACGAAC in both the WT and infectious clone SARS-CoV. Availability of a SARS-CoV full-length cDNA provides a template for manipulation of the viral genome, allowing for the rapid and rational development and testing of candidate vaccines and therapeutics against this important human pathogen.",
author = "Boyd Yount and Curtis, {Kristopher M.} and Fritz, {Elizabeth A.} and Hensley, {Lisa E.} and Jahrling, {Peter B.} and Erik Prentice and Denison, {Mark R.} and Thomas Geisbert and Baric, {Ralph S.}",
year = "2003",
month = "10",
day = "28",
doi = "10.1073/pnas.1735582100",
language = "English (US)",
volume = "100",
pages = "12995--13000",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "22",

}

TY - JOUR

T1 - Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

AU - Yount, Boyd

AU - Curtis, Kristopher M.

AU - Fritz, Elizabeth A.

AU - Hensley, Lisa E.

AU - Jahrling, Peter B.

AU - Prentice, Erik

AU - Denison, Mark R.

AU - Geisbert, Thomas

AU - Baric, Ralph S.

PY - 2003/10/28

Y1 - 2003/10/28

N2 - A previously undescribed coronavirus (CoV) is the etiologic agent responsible for severe acute respiratory syndrome (SARS). Using a panel of contiguous cDNAs that span the entire genome, we have assembled a full-length cDNA of the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV) that contained the expected marker mutations inserted into the component clones. Recombinant viruses replicated as efficiently as WT virus and both were inhibited by treatment with the cysteine proteinase inhibitor (2S,3S)-transepoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester. In addition, subgenomic transcripts were initiated from the consensus sequence ACGAAC in both the WT and infectious clone SARS-CoV. Availability of a SARS-CoV full-length cDNA provides a template for manipulation of the viral genome, allowing for the rapid and rational development and testing of candidate vaccines and therapeutics against this important human pathogen.

AB - A previously undescribed coronavirus (CoV) is the etiologic agent responsible for severe acute respiratory syndrome (SARS). Using a panel of contiguous cDNAs that span the entire genome, we have assembled a full-length cDNA of the SARS-CoV Urbani strain, and have rescued molecularly cloned SARS viruses (infectious clone SARS-CoV) that contained the expected marker mutations inserted into the component clones. Recombinant viruses replicated as efficiently as WT virus and both were inhibited by treatment with the cysteine proteinase inhibitor (2S,3S)-transepoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester. In addition, subgenomic transcripts were initiated from the consensus sequence ACGAAC in both the WT and infectious clone SARS-CoV. Availability of a SARS-CoV full-length cDNA provides a template for manipulation of the viral genome, allowing for the rapid and rational development and testing of candidate vaccines and therapeutics against this important human pathogen.

UR - http://www.scopus.com/inward/record.url?scp=0242268397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242268397&partnerID=8YFLogxK

U2 - 10.1073/pnas.1735582100

DO - 10.1073/pnas.1735582100

M3 - Article

VL - 100

SP - 12995

EP - 13000

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 22

ER -